The prognostic role of (68)Ga-PSMA11 PET-based response in prostate cancer patients undergoing taxane-based chemotherapy. Lunger L, Chantadisai M, Karimzadeh A, Rauscher I, et al. J Nucl Med 2022 Dec 29:jnumed.122.264962. doi: 10.2967/jnumed.122.264962.

Read + Share

Amedeo Smart

Independent Medical Education

Lunger L, Chantadisai M, Karimzadeh A, Rauscher I, et al. The prognostic role of (68)Ga-PSMA11 PET-based response in prostate cancer patients undergoing taxane-based chemotherapy. J Nucl Med 2022 Dec 29:jnumed.122.264962. doi: 10.2967/jnumed.122.264962.
PMID: 36581373